ArticleScientific reports2024

Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study.

Shuyi Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.